Intelligence · Clinical Pipeline
Neurology & CNS R&D Pipeline
Alzheimer's, Parkinson's, epilepsy, MS, and CNS pipeline assets tracked by phase and sponsor.
- Programs
- 676
Quick answer
Neurology & CNS: NovaPharmaNews indexes 676 neurology & cns clinical pipeline programs from ClinicalTrials.gov with phase, modality, NCT identifiers, and sponsor company links. Alzheimer's, Parkinson's, epilepsy, MS, and CNS pipeline assets tracked by phase and sponsor.
Top sponsors
- HOFFMANN-LA ROCHE 38 programs
- Teva Pharma 37 programs
- Takeda 32 programs
- BRIGHT MINDS BIOSCIENCES 30 programs
- United Therapeutics Europe 26 programs
- Chinese Academy of 24 programs
- Anaxis Pharma 22 programs
- Novartis India 21 programs
- Jazz Pharmaceuticals Ireland 20 programs
- NEUROCRINE BIOSCIENCES 18 programs
- SUPERNUS PHARMACEUTICALS 18 programs
- Acadia Pharmaceuticals 16 programs
-
Vildagliptin 50 mg bid
The First People's Hospital of Lianyungang
Parkinson's Disease
1 trial -
Vitamin D3
Hospital Authority, Hong Kong
Major Depression
1 trial -
probiotics
Hospital Authority, Hong Kong
Parkinson's Disease (PD)
1 trial -
rivastigmine patch
Dong Wang
Alzheimer's Disease
1 trial
Frequently asked questions
How many neurology & cns pipeline programs are tracked?
676 programs match this therapeutic area based on indication text, program name, and registry metadata.
Where does pipeline data come from?
ClinicalTrials.gov records linked to NovaPharmaNews company profiles. Verify on ClinicalTrials.gov before investment decisions.
Data attribution: Data sources · All pipeline programs